Cargando…

The effects of lisdexamfetamine dimesylate on eating behaviour and homeostatic, reward and cognitive processes in women with binge-eating symptoms: an experimental medicine study

Lisdexamfetamine dimesylate (LDX) is the only drug currently approved by the FDA for the treatment of Binge-Eating Disorder (BED), but little is known about the behavioural mechanisms that underpin the efficacy of LDX in treating BED. We examined the behavioural and neural effects of an acute dose o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneider, Elizabeth, Martin, Elizabeth, Rotshtein, Pia, Qureshi, Kasim L., Chamberlain, Samuel R., Spetter, Maartje S., Dourish, Colin T., Higgs, Suzanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744047/ https://www.ncbi.nlm.nih.gov/pubmed/35013131 http://dx.doi.org/10.1038/s41398-021-01770-4

Ejemplares similares

The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA
por: Ágh, Tamás, et al.
Publicado: (2016)

Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
por: Griffiths, Kristi R., et al.
Publicado: (2021)

Associations Between Core Symptoms of Attention Deficit Hyperactivity Disorder and Both Binge and Restrictive Eating
por: Kaisari, Panagiota, et al.
Publicado: (2018)

Interactions between metabolic, reward and cognitive processes in appetite control: Implications for novel weight management therapies
por: Higgs, Suzanne, et al.
Publicado: (2017)

Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol
por: Griffiths, Kristi R., et al.
Publicado: (2019)

Evaluating functional disability in clinical trials of lisdexamfetamine dimesylate in binge eating disorder using the Sheehan Disability Scale
por: Yee, Karen S., et al.
Publicado: (2020)

Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials
por: McElroy, Susan L, et al.
Publicado: (2016)

Cognitive Control of Eating: the Role of Memory in Appetite and Weight Gain
por: Higgs, Suzanne, et al.
Publicado: (2018)

Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double‐blind, placebo‐controlled trials in adults with binge‐eating disorder
por: McElroy, Susan L., et al.
Publicado: (2017)

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder
por: Gasior, Maria, et al.
Publicado: (2017)

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
por: Guerdjikova, Anna I, et al.
Publicado: (2016)

Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
por: Srivastava, Gitanjali, et al.
Publicado: (2019)

A Systematic Review of the Safety of Lisdexamfetamine Dimesylate
por: Coghill, David R., et al.
Publicado: (2014)

Pharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate
por: Roesch, Benno, et al.
Publicado: (2013)

The effect of intranasal insulin on appetite and mood in women with and without obesity: an experimental medicine study
por: Schneider, Elizabeth, et al.
Publicado: (2022)

Relative Bioavailabilities of Lisdexamfetamine Dimesylate and d-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or Drink
por: Ermer, James, et al.
Publicado: (2016)

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
por: Pennick, Michael
Publicado: (2010)

Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy
por: Ermer, James C., et al.
Publicado: (2016)

Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
por: Najib, Jadwiga, et al.
Publicado: (2017)

Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder
por: Adler, Lenard A, et al.
Publicado: (2009)

Effect of BMI and Binge Eating on Food Reward and Energy Intake: Further Evidence for a Binge Eating Subtype of Obesity
por: Dalton, Michelle, et al.
Publicado: (2013)

Associations between inattention and impulsivity ADHD symptoms and disordered eating risk in a community sample of young adults
por: Martin, E., et al.
Publicado: (2022)

Top-down guidance of attention to food cues is enhanced in individuals with overweight/obesity and predicts change in weight at one-year follow up
por: Kaisari, Panagiota, et al.
Publicado: (2018)

Evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression
por: Gutiérrez Casares, J.R., et al.
Publicado: (2022)

Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use
por: Jain, Rakesh, et al.
Publicado: (2013)

Long‐term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention‐deficit/hyperactivity disorder
por: Ichikawa, Hironobu, et al.
Publicado: (2019)

Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe
por: Siffel, Csaba, et al.
Publicado: (2020)

Neurocognitive findings in young adults with binge eating disorder
por: Grant, Jon E., et al.
Publicado: (2019)

In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression
por: Gutiérrez-Casares, José Ramón, et al.
Publicado: (2023)

Retention, engagement, and binge‐eating outcomes: Evaluating feasibility of the Binge‐Eating Genetics Initiative study
por: Flatt, Rachael E., et al.
Publicado: (2022)

Dialectical behavior therapy adapted for binge eating compared to cognitive behavior therapy in obese adults with binge eating disorder: a controlled study
por: Lammers, Mirjam W., et al.
Publicado: (2020)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
por: Joseph, Alain, et al.
Publicado: (2016)

A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
por: Zimovetz, Evelina A., et al.
Publicado: (2017)

Identification, Characterization and Quantification of Process-Related and Degradation Impurities in Lisdexamfetamine Dimesylate: Identifiction of Two New Compounds
por: Gao, Shenghua, et al.
Publicado: (2018)

Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
por: Ichikawa, Hironobu, et al.
Publicado: (2020)

Influence of Lisdexamfetamine Dimesylate on Early Ejaculation—Results from a Double-Blind Randomized Clinical Trial
por: Haghighi, Mohammad, et al.
Publicado: (2021)

Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa
por: Dixon, Laura, et al.
Publicado: (2023)

Correction to: Dialectical behavior therapy adapted for binge eating compared to cognitive behavior therapy in obese adults with binge eating disorder: a controlled study
por: Lammers, Mirjam W., et al.
Publicado: (2021)

Processes and pathways to binge eating: development of an integrated cognitive and behavioural model of binge eating
por: Burton, Amy L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tpip7t98cptiaav1onpsnc3875